Regeneron has at least two promising weight loss medicines in its pipeline. One of them is called olatorepatide. Regeneron licensed this medicine from a China-based company. Olatorepatide mimics the ...

Rossari Biotech’s revenue of INR 619.9 crores missed the forecast of INR 692 million equivalent in the supplied data by 3.61% ...

Beijing proposes controls on five biomedical technologies but exempts licensing, partnerships and contract research, keeping ...

LB2501 is designed as an off-the-shelf, single-infusion treatment; its planned U.S. Phase 1/2 study will assess safety and ...

SpudCells may one day produce new medicines and materials. But first scientists have to improve them — and make sure they ...

In the table below, we highlight what makes each of the best AI courses stand out, as well as their respective cost and length. In this table, we list the best AI courses in order of their estimated ...

I see the risk-reward as favorable, with a strong balance sheet, upgraded guidance, and multiple expansion potential driven by new product commercialization. NovoCure describes their mission as ...

President Droupadi Murmu on Monday told members of the 66th National Defence College (NDC) Course that India’s security ...

Sana Biotechnology trades at a steep discount despite promising T1D assets UP421 and SC451. Check out why SANA stock is a buy ...

Dr Villoo Morawala Patell, founder of Avesthagen and Avestagenome Project International, discusses how India can turn its ...